Pages that link to "Q24538036"

The following pages link to Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells (Q24538036):

Displaying 39 items.

• Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein (Q24794459) (← links)
• mTOR and cancer therapy (Q28268516) (← links)
• The TOR pathway: a target for cancer therapy (Q29614242) (← links)
• Targeting the transforming growth factor-beta signaling pathway in human cancer (Q33517772) (← links)
• Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients (Q33614767) (← links)
• Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells. (Q33709971) (← links)
• Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells (Q34005315) (← links)
• TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex (Q34287199) (← links)
• National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing (Q34422537) (← links)
• Signaling mechanisms that suppress the cytostatic actions of rapamycin (Q35187701) (← links)
• Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications (Q35328276) (← links)
• Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways (Q35555383) (← links)
• Novel agents that downregulate EGFR, HER2, and HER3 in parallel (Q35833034) (← links)
• Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk (Q35876331) (← links)
• Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option (Q35994885) (← links)
• TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. (Q36001319) (← links)
• (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization (Q36057085) (← links)
• Targeting the TGFβ signalling pathway in disease (Q36462348) (← links)
• Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints (Q36792593) (← links)
• CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. (Q37154185) (← links)
• Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms (Q37172857) (← links)
• Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes (Q37185312) (← links)
• Identification of genes, including the gene encoding p27Kip1, regulated by serine 276 phosphorylation of the p65 subunit of NF-kappaB (Q37207428) (← links)
• A novel class of cyclin-dependent kinase inhibitors identified by molecular docking act through a unique mechanism (Q37447838) (← links)
• A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells (Q37700278) (← links)
• FKBP38-Bcl-2 interaction: a novel link to chemoresistance (Q37875559) (← links)
• Defective TGF-beta signaling sensitizes human cancer cells to rapamycin (Q40093525) (← links)
• Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling (Q40095128) (← links)
• Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. (Q40415912) (← links)
• Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes (Q40517888) (← links)
• Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. (Q41317499) (← links)
• Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs (Q43121941) (← links)
• Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. (Q44522486) (← links)
• Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells (Q44830447) (← links)
• Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. (Q44945718) (← links)
• Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy (Q45283332) (← links)
• No evidence for tumorigenesis of AAV vectors in a large-scale study in mice. (Q45885410) (← links)
• A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells (Q49510072) (← links)
• Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway (Q91995064) (← links)